Clinical Scorecard: Approaches to Implementing Cascade Genetic Testing: Attention to Detail Matters

At a Glance

Key Highlights

• Cascade genetic testing can significantly improve early detection and prevention strategies for at-risk relatives.

• Effective communication and education are essential in the cascade testing process to ensure understanding and participation.

• Engagement of healthcare providers in the referral process is crucial for successful implementation of cascade testing.

Guideline-Based Recommendations

Diagnosis

• Genetic testing should be offered to individuals with a personal or family history suggestive of HBOC or LS (Source: National Comprehensive Cancer Network).

Management

• Management strategies should include risk-reducing surgeries, enhanced surveillance, and chemoprevention for individuals identified as high-risk (Source: American Society of Clinical Oncology).

Monitoring & Follow-up

• Regular follow-up appointments should be scheduled to monitor for cancer development and to discuss ongoing risk management options (Source: National Cancer Institute).

Risks

• Patients should be informed about the psychological impact of genetic testing and the potential for discrimination based on genetic information (Source: Genetics Home Reference).

Patient & Prescribing Data

Genetic testing can lead to significant changes in management for at-risk individuals, including increased surveillance and preventive measures (Source: Journal of Clinical Oncology).

Clinical Best Practices

• Utilize a multidisciplinary team approach to provide comprehensive care for patients undergoing genetic testing (Source: American College of Medical Genetics).

• Ensure informed consent is obtained prior to testing, including discussions about the implications of test results (Source: National Society of Genetic Counselors).

• Provide genetic counseling to help patients understand their results and the impact on family members (Source: National Society of Genetic Counselors).

Related Resources & Content

1. JAMA Network Open, 2023 -- Differences in Cascade Genetic Testing Among Families With Hereditary Cancer Risk

2. The ASCO Post, 2020 -- Should Restrictions on Genetic Testing Be Loosened?

3. CDC, 2023 -- Tier 1 Genomics Applications and their Importance to Public Health

4. JAMA Network Open, 2023 -- A Multilevel Intervention to Identify Individuals for Genetic Testing and Treatment: The IGNITE-TX Pilot Randomized Clinical Trial

5. JAMA Network Open, 2023 -- Implementation Strategies in Cascade Genetic Testing—The Devil Is in the Details

6. the pathologist — Genetic Panel Testing: Points of View (Marilyn Bui)

7. the pathologist — The Power of Pedigree

8. Tier 1 Genomics Applications and their Importance to Public Health | CDC

9. A Multilevel Intervention to Identify Individuals for Genetic Testing and Treatment: The IGNITE-TX Pilot Randomized Clinical Trial | Oncology | JAMA Network Open | JAMA Network

10. Implementation Strategies in Cascade Genetic Testing—The Devil Is in the Details | Oncology | JAMA Network Open | JAMA Network